Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$135,000.00
May 1, 2011
A novel investigation of functional pathoanatomy and outcomes of lumbar spinal stenosis 5 years following diagnosis
$275,000.00
May 1, 2011
Enhancing Participation In the Community by improving Wheelchair Skills (EPIC Wheels): A randomized controlled trial.
$150,000.00
May 1, 2011
Directed differentiation of human embryonic stem cells towards thymic epithelium for the purpose of inducing immune tolerance to stem cell-derived tissue upon transplantation
$105,000.00
May 1, 2011
Confidence, Mobility, and Participation with using a Wheelchair: A study of aging wheelchair users
$70,000.00
May 1, 2011
Anti-obesity and Antihypertensive Treatments in the Prevention of Vascular Pathologies and Sexual Dysfunction
$105,000.00
May 1, 2011
Identifying Frequency and Mutation Spectrum of Genes Mediating Susceptibility to Obesity in the LABS Cohort
$105,000.00
May 1, 2011
Phylogenetic Clustering and Epidemiological Implications for HIV/HCV Coinfections
$105,000.00
May 1, 2011
Genetic architecture and determinants of plasma fibrinogen levels
$70,000.00
May 1, 2011
Angiopoietin-1 mimetics: new therapeutic agents for cancer treatment.
$150,000.00
May 1, 2011
Sucrose-Fed Model of Gestational Insulin Resistance: Mechanism, Modulation and Impact on Pregnant Rat